Diagnos (TSXV-ADK) (OTCQB-DGNOF), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena Vista Sinaloa, the largest ophthalmological hospital in Sinaloa State, Mexico. In Mexico there are 18 million diabetics with a 23% prevalence in people of 20 years or more; the seriousness of these cases is… Continue reading Diagnos $ADK $DGNOF Announces Pilot with Sinaloa Hospital
Tag: blindness
Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), BROSSARD, Quebec, June 09, 2021 (GLOBE NEWSWIRE) — Diagnos Inc. (“DIAGNOS” or the “Company”) (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, announces today the signing of a 2-month pilot with Hospital Oftalmológico Buena… Continue reading Diagnos $ADK Announces a Pilot with Hospital Oftalmologico Buena Vista Sinaloa
Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. (TSX Venture: ADK) (OTCQB: DGNOF) (FRA: 4D4A), a leader in early detection of critical health issues, is pleased to announce the signing of a multi-year agreement with IRIS The Visual Group (1990) Inc. (“IRIS”), creating a world leading platform launch for the deployment and enhancement of Artificial Intelligence (“AI”) based tests, screening for… Continue reading Diagnos $ADK IRIS, a New Look #Vision Group Company, Teams up with Diagnos in a Multi-Year Agreement to Implement #AI #Technology with Support from INVEST-AI Program
Diagnos Inc. $ADK $DGNOF #Interview with InvestorIntel – #AI #Healthcare #Technology for #Diabetic #BlindnessPrevention
Diagnos Inc. $ADK $DGNOF #AI #healthcare #technology #diabetics #blindness #StrokePrevention Interview: https://youtu.be/B7elDQ7bgb4 InvestorIntel Interview with Andre Larente, President of Diagnos Inc.
Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People
Diagnos Inc. TSXV-ADK OTCQB: DGNOF a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial Intelligence (AI), announces today the signing of an exclusive distribution agreement with Diagnos Europe GmbH (“Diagnos Europe”), a new partner for DIAGNOS to tackle the strategically important DACH countries in the European… Continue reading Diagnos $ADK $DGNOF Enters into Exclusive Distribution Agreement to Access Massive Global Healthcare Market in DACH Countries and Central Europe of Over 140 Million People